Tuesday | August 24, 2021
Morning Wire
00:00
FDA Grants Full Approval to Pfizer-BioNTech Vaccine
This chapter covers the transition of the Pfizer-BioNTech vaccine from emergency use to full FDA approval for those aged 16 and older. It highlights the approval process, its implications for vaccine confidence, and potential mandates in various settings.
Play episode from 01:44
Transcript
